髋臼发育不良患者初次髋关节镜治疗:最低5年随访已发表临床结局的系统综述
该系统综述纳入9项研究,评估外侧中心边缘角(LCEA)<25°患者初次髋关节镜术后至少5年结局,结果显示临床结局满意、患者满意度高且患者报告结局(PROs)显著改善;与无发育不良患者相比,术前、术后及变化值PROs以及失败、再手术、翻修率均无显著差异;结局与LCEA分层之间无总体显著相关性。
要点
- LCEA<25°患者初次髋关节镜术后≥5年随访临床结局满意,患者报告结局显著改善。
- 发育不良与无发育不良患者相比,术前、术后及变化值PROs以及失败、再手术、翻修率无显著差异。
- 结局与LCEA分层之间无总体显著相关性。
核心结论
- 经仔细选择的LCEA<25°患者行髋关节镜在中长期随访中可获得成功,临床结局和失败率可能与LCEA正常患者相当。
- LCEA是单一二维影像学指标,不能区分不稳定与撞击或其组合,需未来研究阐明这些差异。
- 髋关节发育不良可能不是单纯髋关节镜的绝对禁忌证,可作为一种可行干预并考虑分期未来行髋臼周围截骨术(PAO)。
- 本综述不提示髋关节镜改变发育不良的自然史,因此发育不良患者应由合适的保髋专家告知PAO的潜在效用。
研究设计与样本
- 系统综述,证据等级4级,按照PRISMA指南进行综合文献检索。
- 纳入标准为评估LCEA<25°患者初次髋关节镜术后≥5年随访结局的研究,共纳入9项研究。
- 采用非随机研究方法学指数评分系统进行偏倚风险评估,证据等级依据牛津循证医学中心标准确定。
主要发现
- LCEA<25°患者临床结局满意、患者满意度高,随访时间从≥5年至10年,患者报告结局(PROs)术后显著改善。
- 比较发育不良与无发育不良患者的研究未显示术前、术后或变化值PROs以及失败、再手术或翻修率有显著差异。
- 结局与LCEA分层之间无总体显著相关性。
关键数值与推荐
- 纳入研究的LCEA阈值为<25°。
- 随访时间范围为≥5年至10年。
- 纳入研究数量为9项。
临床怎么用
- 作者认为,经仔细选择的LCEA<25°患者行髋关节镜在中长期随访中可获得成功,临床结局和失败率可能与LCEA正常患者相当。
- 作者认为,髋关节发育不良可能不是单纯髋关节镜的绝对禁忌证,可作为一种可行干预并考虑分期未来行PAO。
- 作者指出,本综述不提示髋关节镜改变发育不良的自然史,发育不良患者应由合适的保髋专家告知PAO的潜在效用。
局限性
- LCEA是单一二维影像学指标,不能区分不稳定与撞击或其组合,需未来研究阐明这些差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hip arthroscopy in patients with borderline hip dysplasia has satisfactory outcomes at short-term follow-up; however, the data on midterm outcomes are inconsistent, and failure rates are high in some studies, limiting understanding of the role and utility of hip arthroscopy in this patient cohort. PURPOSE: To provide an up-to-date, evidence-based review of the clinical outcomes of primary hip arthroscopy in patients with frank or borderline hip dysplasia at ≥5-year follow-up and report the failure rate and progression to total hip arthroplasty in this cohort. STUDY DESIGN: Systematic review; Level of evidence, 4. METHODS: A comprehensive literature search was performed according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Studies were included if they evaluated outcomes of primary hip arthroscopy in patients with lateral center-edge angle (LCEA) <25° at ≥5-year follow-up. Risk of bias assessment was performed using the methodological index for non-randomized studies scoring system. Level of evidence was determined using criteria from the Oxford Centre for Evidence-Based Medicine. RESULTS: Nine studies were included in this review. Patients with LCEA <25° demonstrated satisfactory clinical outcomes, high patient satisfaction, and significant postoperative improvements in patient-reported outcomes (PROs) at follow-up ranging from a ≥5 to 10 years. Studies comparing patients with dysplasia to those without did not demonstrate significant differences in preoperative, postoperative, or delta PROs or in failure, reoperation, or revision rates. There was no overall significant correlation between outcomes and LCEA stratification. CONCLUSION: Hip arthroscopy in carefully selected patients with LCEA <25° can be successful at mid- to long-term follow-up and may provide clinical outcomes and failure rates comparable with patients with normal LCEA, understanding that this is a singular, 2-dimensional radiographic measure that does not differentiate instability from impingement or combinations thereof, warranting future studies delineating these differences. These findings suggest that hip dysplasia may not be an absolute contraindication for isolated hip arthroscopy and may serve as a viable intervention with consideration of staged future periacetabular osteotomy (PAO). Importantly, this review does not suggest that hip arthroscopy alters the natural history of dysplasia; therefore, patients with dysplasia should be counseled on the potential utility of PAO by appropriate hip preservation specialists.
引用
- Boos AM, Nagelli CV, Okoroha KR, et al. Primary Hip Arthroscopy in Patients With Acetabular Dysplasia: A Systematic Review of Published Clinical Outcomes at Minimum 5-Year Follow-up. Am J Sports Med. 2024. PMID: 38333917. doi:10.1177/03635465231197177
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。